Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure is a research paper published in JACC Heart Failure (2022). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Innovative Medicines Initiative
Grant: 115974
National Institutes of Health
Grant: DK07011
Gilead Sciences
Grant: 917.15.306
Janssen Pharmaceuticals
Novartis
Abbott Diagnostics
Horizon 2020 Framework Programme
Novo Nordisk
Boehringer Ingelheim
AbbVie
AstraZeneca
Merck
Astellas Pharma US
Bayer
Dutch Research Council (NWO)
European Federation of Pharmaceutical Industries and Associations
Fields of Study
MeSH Terms
Keywords